Evidence map›Paper›PMID 37074659›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

The Imaging Flow Cytometry-Based Cytokinesis-Block MicroNucleus (CBMN) Assay.

Ruth C Wilkins, Matthew Rodrigues, Lindsay A Beaton-Green

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ruth C WilkinsConsumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, ON, Canada. Ruth.Wilkins@hc-sc.gc.ca.
Matthew RodriguesLuminex Corporation, Seattle, WA, USA.
Lindsay A Beaton-GreenConsumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, ON, Canada.
Health Canada · CALuminex (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dose of ionizing radiation received by an individual can be determined using biodosimetry methods which measure biomarkers of exposure in tissue samples from that individual. These markers can be expressed in many ways, including DNA damage and repair processes. Following a mass casualty event involving radiological or nuclear material, it is important to rapidly provide this information to medical responders to assist in the medical management of potentially exposed casualties. Traditional methods of biodosimetry rely on microscope analysis, making them time-consuming and labor-intensive. To increase sample throughput following a large-scale radiological mass casualty event, several biodosimetry assays have been adapted for analysis by imaging flow cytometry. This chapter briefly reviews these methods with a focus on the most current methodology to identify and quantify micronuclei in binucleated cells within the cytokinesis-block micronucleus assay using an imaging flow cytometer.

Indexed as

CytokinesisRadiometryCell NucleusFlow CytometryLymphocytesMicronucleus TestsBiodosimetryChromosome damageCytokinesis-block micronucleus assayImaging flow cytometryLymphocytes

Identifiers

PMID37074659
OpenAlexW4366351948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.